Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2026 ,inter alia, to consider and approve the audited results for the quarter and financial year ended on 31st March, 2026 and to consider recommendation of dividend, if any.
Jenburkt Pharmaceuticals Ltd Press Release Apr 28 2026
Earlier from Jenburkt Pharmaceuticals
- Jenburkt Pharmaceuticals Ltd Press Release Apr 07 2026
- Jenburkt Pharmaceuticals Ltd Press Release Mar 23 2026